Dnovobio is a developer of a direct reprogramming technology intended to create any cell, tissue, or organ on demand.
Business Model:
Revenue: $0
Employees: 1-10
Address: -
City: Silicon Valley
State: CA
Zip: 94027
Country: US
Dnovobio is a developer of a direct reprogramming technology intended to create any cell, tissue, or organ on demand. Its company&s;s platform converts skin into functional brain cells. The company is currently operating in Stealth mode.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2022 | Seed Round | 15 | $2.7M |
Ataria Charles Songhurst Claudio Pinkus Duro Ventures Felicis Ventures Jason Hodges Jean Pigozzi Joey Krug Justin Mateen Max Kolysh Paul Buchheit Pioneer Fund Soma Capital Y Combinator Yintai Investment Company Ataria Charles Songhurst Claudio Pinkus Duro Ventures Felicis Ventures Jason Hodges Jean Pigozzi Joey Krug Justin Mateen Max Kolysh Paul Buchheit Pioneer Fund Soma Capital Y Combinator Yintai Investment Company |
1/2018 | Seed Round | 1 | - |
Soma Capital Soma Capital |
1/2018 | Seed Round | 1 | - |
Soma Capital Soma Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|